HCT Core Topics Connection Module: Conditioning Regimens Used in Hematopoietic Cell Transplantation
This module will identify the goals of administering a conditioning regimen prior to HCT, discuss the non-hematologic dose limiting toxicities of chemotherapy agents commonly utilized in conditioning regimens, differentiate between myeloablative, reduced-intensity, and non-myeloablative conditioning regimens, and select an appropriate conditioning regimen for a patient based on disease and patient specific factors.
Binni Kunvarjee, PharmD, BCOP; Memorial Sloan Kettering Cancer Center
Maggie Nelson, PharmD, BCOP; The University of Kansas Health System
Vinita Pai, PharmD, MS; The Ohio State University and Nationwide Children’s Hospital
|Access Date||Quiz Result||Score||Actions|